Sean Arora, MD
Provider
Specialties: Obesity Medicine · Telemedicine · Weight Management
About Sean
Dr. Sean Arora is a board-certified physician licensed in all 50 states and the founder of Arora Health, the 50-state telemedicine network that delivers clinical oversight for Trimi Health. With expertise in family medicine, telehealth innovation, and evidence-based protocol development, he leads one of the nation's most comprehensive medical-oversight and compliance networks. Dr. Arora and the Arora Health providers review patient eligibility for compounded GLP-1 weight management therapy, evaluating each new patient's medical history, BMI, and weight-related comorbidities (type 2 diabetes, hypertension, sleep apnea, dyslipidemia, cardiovascular disease) against FDA labeling thresholds and obesity-medicine clinical guidelines. The clinical focus spans obesity medicine, telemedicine-based chronic care, and metabolic health, working within Trimi's evidence-based protocols, which align with the Endocrine Society's 2024 Obesity Pharmacotherapy Guideline and the AACE Comprehensive Type 2 Diabetes Algorithm 2024. Clinical review covers contraindications such as personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, and severe gastrointestinal disease, and confirms that prescriptions are dispensed only by Trimi's named 503A community sterile compounding pharmacy (BelieveRx, Texas State Board pharmacy license #35264). Patient education emphasizes common GLP-1 adverse effects (nausea, vomiting, gallbladder events, acute kidney injury risk if severe GI side effects cause dehydration) and the importance of dose titration to maximize tolerability. Trimi's compounded medications are prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs.
Experience
Active board-certified clinician
Board Certifications
Active medical license
Licensed in 50 states
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY
Questions about Sean's role at Trimi
What patients commonly ask about clinician review at Trimi Health.
Who is Dr. Sean Arora?
Sean Arora, MD, of Arora Health, Trimi's provider network, is a licensed provider who reviews patients for compounded GLP-1 weight management therapy on Trimi's platform. He practices through the Arora Health 50-state telemedicine network, where each new patient's medical history, BMI, and weight-related comorbidities are evaluated before any compounded prescription is issued.
What does Dr. Arora review when a patient submits an intake?
He reviews the patient's full medical history, current medications, prior weight-loss interventions, BMI calculation, and weight-related comorbidities (type 2 diabetes, hypertension, sleep apnea, dyslipidemia, cardiovascular disease). He assesses clinical appropriateness against the prescribing information and obesity-medicine clinical guidelines, then screens for contraindications.
What contraindications does Dr. Arora screen for?
Personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia type 2 (MEN 2) syndrome, history of pancreatitis, severe gastrointestinal disease, severe renal impairment, current pregnancy or breastfeeding, and any prior serious hypersensitivity reaction to GLP-1 receptor agonists. These contraindications align with FDA prescribing information for semaglutide and tirzepatide.
How does Arora Health work with Trimi?
Arora Health is Trimi's clinical infrastructure partner, a 50-state medical service organization (MSO) and 50-state telemedicine provider network. Dr. Arora is one of the licensed providers in Arora's clinician network who handles patient reviews on Trimi's platform. Arora maintains state-by-state provider licensing and credentialing so Trimi can offer care nationwide.
Who actually prescribes the medication?
A licensed US provider within the Arora Health clinician network, Dr. Arora or another credentialed prescriber, writes the prescription after reviewing the intake. Compounded medications are then dispensed by Trimi's 503A community sterile compounding pharmacy partner, BelieveRx (Texas State Board pharmacy license #35264).
Are Trimi's compounded medications FDA-approved?
No. Each compounded medication is prepared per individual prescription by a state-licensed 503A pharmacy and is not FDA-approved as a drug. FDA does not review compounded preparations for safety, effectiveness or quality before they are dispensed.
What states is Dr. Arora licensed in?
Dr. Arora's individual licensure is listed in the Licensed States card on this page. Through the broader Arora Health network, Trimi has access to licensed prescribers in all 50 US states, if Dr. Arora is not the assigned reviewer for your state, another credentialed Arora provider handles your intake under the same clinical protocols.
What clinical guidelines does Dr. Arora follow?
His review aligns with the Endocrine Society's 2024 Obesity Pharmacotherapy Guideline, the AACE Comprehensive Type 2 Diabetes Algorithm 2024, and FDA prescribing information for the relevant active ingredients. He emphasizes patient education on common GLP-1 adverse effects (nausea, vomiting, gallbladder events, acute kidney injury risk from dehydration) and the importance of dose titration for tolerability.
Treatment information reviewed under this clinical network
Programs and clinical guides for which Sean and other clinicians in the Arora Health network review eligibility.
Compounded semaglutide program
Program overview, dosing schedule and plan terms
Compounded tirzepatide program
Program overview, dosing schedule and plan terms
State-by-state availability
50-state Arora Health provider network · pharmacy mapping
Patient FAQ
Pricing, dispensing, refills, cancellations, eligibility
Medical review policy
How Trimi clinicians review patient eligibility and content
Editorial policy
Sourcing, clinical citations, dating, and review cadence
Profile last reviewed: 2026-09-03. Trimi providers are independent licensed practitioners. See our medical review policy for how Trimi handles clinical oversight, and our editorial policy for how content is produced.
Get matched with a board-certified provider
Provider review typically takes 12–24 hours. Compounded semaglutide from $99/mo on the annual plan ($1,188 billed upfront, 12-month commitment); compounded tirzepatide from $125/mo on the annual plan ($1,500 billed upfront, 12-month commitment).